Satter Management

Latest statistics and disclosures from Alerce Investment Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ANNX, AKBA, VRNA, AMWL, AADI, and represent 100.00% of Alerce Investment Management's stock portfolio.
  • Added to shares of these 2 stocks: VRNA (+$5.9M), AMWL.
  • Started 2 new stock positions in VRNA, AMWL.
  • Reduced shares in these 4 stocks: AKBA (-$9.8M), American Well Corp (-$8.5M), ALRN (-$5.5M), AADI.
  • Sold out of its positions in ALRN, American Well Corp.
  • Alerce Investment Management was a net seller of stock by $-16M.
  • Alerce Investment Management has $62M in assets under management (AUM), dropping by -34.46%.
  • Central Index Key (CIK): 0001844002

Tip: Access up to 7 years of quarterly data

Positions held by Satter Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Alerce Investment Management

Alerce Investment Management holds 5 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Annexon (ANNX) 70.4 $44M 7.4M 5.92
 View chart
Akebia Therapeutics (AKBA) 12.2 $7.6M -56% 5.7M 1.32
 View chart
Verona Pharma Sponsored Ads (VRNA) 9.5 $5.9M NEW 206k 28.77
 View chart
American Well Corp Com Cl A New (AMWL) 8.0 $5.0M NEW 524k 9.48
 View chart
Aadi Bioscience (AADI) 0.0 $1.4k -99% 659.00 2.06
 View chart

Past Filings by Alerce Investment Management

SEC 13F filings are viewable for Alerce Investment Management going back to 2020